Kristell Lebozec
Hôpital Bichat-Claude-Bernard(FR)
Publications by Year
Research Areas
Platelet Disorders and Treatments, Adipokines, Inflammation, and Metabolic Diseases, Antiplatelet Therapy and Cardiovascular Diseases, Blood groups and transfusion, MicroRNA in disease regulation
Most-Cited Works
- → Irf5 deficiency in macrophages promotes beneficial adipose tissue expansion and insulin sensitivity during obesity(2015)193 cited
- → Safety and Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT017, an Antiplatelet GPVI (Glycoprotein VI) Fab(2019)113 cited
- → Design, development and characterization of ACT017, a humanized Fab that blocks platelet's glycoprotein VI function without causing bleeding risks(2017)90 cited
- → Anionic polymers for decreased toxicity and enhanced in vivo delivery of siRNA complexed with cationic liposomes(2011)77 cited
- → Quality and cost assessment of a recombinant antibody fragment produced from mammalian, yeast and prokaryotic host cells: A case study prior to pharmaceutical development(2018)40 cited
- → Targeting platelet GPVI with glenzocimab: a novel mechanism for inhibition(2022)34 cited
- → Population Pharmacokinetic/Pharmacodynamic Modeling of Glenzocimab (ACT017) a Glycoprotein VI Inhibitor of Collagen‐Induced Platelet Aggregation(2020)34 cited
- → Crucial Role for Endoplasmic Reticulum Stress During Megakaryocyte Maturation(2013)31 cited
- → PO16 Interferon Regulatory Factor-5 (IRF5) contrôle l’inflammation métabolique dans le diabète de type 2(2015)